OLMA OLEMA PHARMACEUTICALS INC

Ownership history in Birchview Capital, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in OLEMA PHARMACEUTICALS INC (OLMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.94% (2025 Q4)
Avg. % of fund
1.93%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 269,000 +95,000 +54.6% 3.94% $6.7M $25.00
2025 Q3 ADDED 174,000 +40,000 +29.9% 1.29% $1.7M $9.79
2025 Q2 INITIATED 134,000 0.57% $571K $4.26
% of Fund (quarterly)    OLMA price (monthly, adj. close)
← Back to Birchview Capital, LP Holdings